The emerging pathogen Candida auris: host interactions and disease drivers.

Area of Science:

• Medical Mycology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Candida auris is a multidrug-resistant fungal pathogen causing hospital-acquired infections with high mortality.
• Clinical isolates show resistance to antifungal drugs, complicating treatment.
• Challenges include persistent colonization, biofilm formation, and diagnostic misidentification.

Purpose of the Study:

• To summarize the clinical spectrum of Candida auris infections.
• To highlight key pathogenic traits and clade-specific differences.
• To discuss emerging strategies for diagnosis, therapy, and prevention.

Main Methods:

• Literature review and synthesis of current knowledge on Candida auris.
• Analysis of clinical data and pathogenic characteristics.
• Exploration of novel diagnostic, therapeutic, and preventative approaches.

Main Results:

• Candida auris infections present a significant global health threat due to multidrug resistance.
• Pathogenic traits and clade variations influence disease presentation and treatment outcomes.
• Emerging strategies show promise for improved detection and management.

Conclusions:

• Effective patient care and infection control necessitate rapid species identification and antifungal susceptibility testing.
• Novel antifungal agents, host-directed therapies, and vaccine development are crucial for future interventions.
• Addressing the challenges posed by Candida auris requires a multifaceted approach encompassing diagnostics, therapeutics, and prevention.